ISO 15798:2022
Ophthalmic implants — Ophthalmic viscosurgical devices
Ophthalmic implants — Ophthalmic viscosurgical devices
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 19
- Дата публикации:
- 17 января 2022 г.
- Издание:
- ISO IS 15798 edition 4 version 1
- ICS:
- 11.040.70
This document is applicable to ophthalmic viscosurgical devices (OVDs), a class of surgical invasive medical devices with viscous and/or viscoelastic properties, intended for use during surgery in the anterior segment of the human eye. OVDs are designed to create and maintain space, to protect intraocular tissues and to manipulate tissues during surgery. This document specifies requirements with regard to safety for the intended performance, design attributes, preclinical and clinical evaluation, sterilization, product packaging, product labelling and information supplied by the manufacturer of these devices.
Abstract
Overview
ISO 15798:2022 - fourth edition - specifies safety and performance requirements for ophthalmic viscosurgical devices (OVDs), a class of surgical invasive medical devices with viscous and/or viscoelastic properties used in the anterior segment of the human eye. OVDs are intended to create and maintain space, protect intraocular tissues and assist tissue manipulation during surgery. The standard covers design attributes, preclinical and clinical evaluation, sterilization, packaging, labelling and information supplied by the manufacturer.
Note: while OVDs are not implants by intended use, the standard recognizes they can share some risks associated with non‑active implants.
Key topics and technical requirements
- Intended performance and design attributes: requirements for device function, usability and delivery system integrity.
- Characterization of components and finished product, including:
- Absolute complex viscosity, shear viscosity and elasticity
- Concentration, molecular mass distribution (where applicable), osmolality, pH, refractive index and spectral transmittance
- Particulates and chemical/biological contaminants
- Design evaluation and biological safety:
- Requirements for preclinical testing (biocompatibility per ISO 10993 series)
- Bacterial endotoxin testing and evaluation of degradation, toxicokinetics and clearance of residual OVD
- Assessments of inflammation and intraocular pressure effects
- Clinical evaluation:
- Clinical investigation design, outcome reporting and standardized endpoints such as corneal endothelial cell density, postoperative inflammation, intraocular pressure changes and adverse events
- Sterilization and residuals:
- Sterilization validation (EO, radiation, moist heat) and acceptable residuals (reference to ISO 10993‑7)
- Packaging and stability:
- Sterile barrier, packaging integrity, protection during storage/transport and labelling (including “Do not use if sterile barrier is breached” guidance)
- Information to be supplied: manufacturer labelling, instructions for use and required technical information.
Applications - who uses ISO 15798:2022
- Medical device manufacturers developing OVDs for cataract, anterior segment and other intraocular surgeries
- Regulatory and quality affairs teams preparing technical files and conformity evidence
- Clinical researchers and trial designers planning OVD clinical investigations
- Sterilization and packaging engineers validating processes and sterile barrier systems
- Ophthalmic surgeons and hospitals referencing safety and labelling expectations
Related standards
ISO 15798:2022 references and aligns with key standards, including:
- ISO 10993 series (biocompatibility)
- ISO 14155 (clinical investigation)
- ISO 14971 (risk management)
- ISO 11135 / ISO 11137 / ISO 17665 (sterilization)
- ISO 11607 (packaging)
Keywords: ISO 15798:2022, ophthalmic viscosurgical devices, OVD, ophthalmic implants, sterilization, biocompatibility, clinical evaluation, viscosity, packaging integrity.
Технические детали
- Технический комитет
- ISO/TC 172/SC 7 - Ophthalmic optics and instruments
- SKU
- ISO 15798:2022
Похожие стандарты
Стандарты, упомянутые в описании
ISO 10993-12:2012
ОтменёнBiological evaluation of medical devices — Part 12: Sample preparation and reference materials
BS EN ISO 10993-7:2026
ДействующийBiological evaluation of medical devices. Ethylene oxide sterilization residuals.
ISO 14155:2026
ДействующийClinical investigation of medical devices for human subjects — Good clinical practice
Overview ISO 14155:2026 sets the international standard for Good Clinical Practice (GCP) in clinical investigations involving medical devices used with human subjects. Developed by ISO, this essentia…
ISO 14971:2007
ДействующийMedical devices - Application of risk management to medical devices
Overview ISO 14971:2007 - Medical devices - Application of risk management to medical devices - defines a systematic process for identifying hazards, estimating and evaluating risks, implementing ris…
ISO 11135:2014
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization…
ISO 11137-2:2013
ДействующийSterilization of health care products — Radiation — Part 2: Establishing the sterilization dose
Overview ISO 11137-2:2013 - “Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose” specifies validated methods to determine the minimum radiation dose requi…
ISO 17665:2024
ДействующийSterilization of health care products — Moist heat — Requirements for the development, validation and routine…
Overview - ISO 17665:2024 (Moist heat sterilization) ISO 17665:2024, "Sterilization of health care products - Moist heat - Requirements for the development, validation and routine control of a steril…
ISO 11607-2:2019
ДействующийPackaging for terminally sterilized medical devices — Part 2: Validation requirements for forming, sealing an…
Overview ISO 11607-2:2019 - Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes - specifies requirements for the developm…